高效调节器疗法:对于囊性纤维化中的微生物景观的影响
Kristina N Valladares1, Luke I Jones2,3, Jarrod W Barnes1,2
1Gregory Fleming James Cystic Fibrosis Research Center, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
International journal of molecular sciences
|November 27, 2024
概括
高效的CFTR调制剂疗法 (HEMT) 改善了囊性纤维化 (CF) 患者的结果,但慢性呼吸道病原体的殖民性仍然存在. 本综述研究了HEMT对CF病原体和肺微生物群在调节器后时代的影响.
科学领域:
- 肺部病理学 肺部病理学
- 微生物学 微生物学
- 遗传学 遗传学 是一个
背景情况:
- 囊性纤维化 (CF) 是由CFTR基因突变引起的遗传疾病,导致肺部粘液清除受损和免疫功能障碍.
- 这使个人容易患上多种耐药病原体的慢性多微生物感染,并使治疗复杂化.
- 高效的CFTR调制剂疗法 (HEMT) 改善了患者的治疗结果,但对慢性感染和肺微生物组的影响尚未完全理解.
研究的目的:
- 审查目前有关HEMT对CF病原体的影响的文献.
- 探索HEMT对CF肺微生物组在调节器后时代的影响.
- 确定有关HEMT对CF肺部感染的影响的知识差距.
主要方法:
- 关于HEMT,CF病原体和肺微生物组的研究文献综述.
- 对HEMT启动后CF患者微生物殖民和感染现有数据的分析.
- 确定研究缺口和未来方向.
主要成果:
- 在许多CF患者中,HEMT已经改善了临床结果,并减少了恶化.
- 尽管有HEMT,但常见的呼吸道病原体的持续殖民继续导致慢性炎症.
- 目前关于HEMT对CF肺微生物组的特定影响的数据有限.
结论:
- 在CF护理中,HEMT代表了显著的进步,但并不能完全解决慢性呼吸道病原体问题.
- 进一步的研究对于了解HEMT对CF肺微生物群和微生物群体的长期影响至关重要.
- 研究后调节器微生物组对于优化治疗策略和管理CF慢性感染至关重要.
相关概念视频
01:24Cystic Fibrosis: Management
142
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
142
01:23Cystic Fibrosis: Pathogenesis
192
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
192
01:28Gene Regulation in Microbial Communities: Quorum Sensing
3
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
3
01:29Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1
01:19Antiasthma Drugs: Leukotriene Modifiers
245
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
245
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K